Home Apricus Biosciences Enrolls First Patients in Phase 2b Clinical Trial ...
 

Keywords :   


Apricus Biosciences Enrolls First Patients in Phase 2b Clinical Trial ...

2015-06-01 20:27:17| Biotech - Topix.net

Apricus Biosciences, Inc. , a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that it has begun enrolling patients in a Phase 2b clinical trial to evaluate Apricus' novel product candidate, fispemifene, a selective estrogen receptor modulator , for the treatment of men with symptomatic secondary hypogonadism also known as low testosterone. The Phase 2 proof-of-concept clinical trial is a randomized, double-blind, placebo-controlled, parallel arm, multi-center study in approximately 160 hypogonadal men aged 18 to 64 who present with sexual dysfunction related to secondary hypogonadism, or low levels of testosterone.

Tags: trial phase patients clinical

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.1150039
28.11Switch Lite()
28.11
28.11 24 31HG
28.11 4000XG 2020
28.11
28.11MLB
28.11M
More »